scholarly journals Mutation Spectrum of Tuberous Sclerosis Complex Patients in Indian Population

Author(s):  
Shruthi Sudarshan ◽  
Atin Kumar ◽  
Arun Gupta ◽  
Neetu Bhari ◽  
Gomathy Sethuraman ◽  
...  

AbstractTuberous sclerosis complex (TSC) is a multiorgan disorder characterized by formation of hamartomas and broad phenotypic spectrum including seizures, mental retardation, renal dysfunction, skin manifestations and brain tubers. It is inherited in an autosomal dominant pattern, caused due to mutation in either TSC1 or TSC2 genes. Seizures are one of the major presenting symptoms of TSC that helps in early diagnosis. The present study describes the mutation spectrum in TSC1 and TSC2 genes in TSC patients and their association with neurocognitive-behavioral phenotypes. Ninety-eight TSC patients were enrolled for TSC genetic testing after detailed clinical and neurobehavioral assessment. Large genomic rearrangement testing was performed by multiplex ligation-dependent probe amplification (MLPA) technique for all cases and Sanger sequencing was performed for MLPA negative cases. Large rearrangements were identified in approximately 1% in TSC1 and 14.3% in TSC2 genes. The present study observed the presence of duplications in two (2%) cases, both involving TSC2/PKD1 contiguous genes which to the best of our knowledge is reported for the first time. 8.1% of small variants were identified in the TSC1 gene and 85.7% in TSC2 gene, out of which 23 were novel variations and no variants were found in six (6.1%) cases. This study provides a representative picture of the distribution of variants in the TSC1 and TSC2 genes in Indian population along with the detailed assessment of neurological symptoms. This is the largest cohort study from India providing an overview of comprehensive clinical and molecular spectrum.

Epilepsia ◽  
2021 ◽  
Vol 62 (3) ◽  
pp. 785-794
Author(s):  
Jakob Stockinger ◽  
Adam Strzelczyk ◽  
Andrea Nemecek ◽  
Michal Cicanic ◽  
Frank Bösebeck ◽  
...  

2017 ◽  
Vol 7 (1) ◽  
Author(s):  
Socratis Avgeris ◽  
Florentia Fostira ◽  
Andromachi Vagena ◽  
Yiannis Ninios ◽  
Angeliki Delimitsou ◽  
...  

2001 ◽  
Vol 25 (3) ◽  
pp. 213-216 ◽  
Author(s):  
Dominique Parain ◽  
Marie J Penniello ◽  
Patrick Berquen ◽  
Thierry Delangre ◽  
Catherine Billard ◽  
...  

PEDIATRICS ◽  
2010 ◽  
Vol 127 (1) ◽  
pp. e117-e125 ◽  
Author(s):  
B. A. Staley ◽  
E. A. Vail ◽  
E. A. Thiele

2009 ◽  
Vol 73 (2) ◽  
pp. 141-146 ◽  
Author(s):  
S. E. Camposano ◽  
E. Greenberg ◽  
D. J. Kwiatkowski ◽  
E. A. Thiele

2013 ◽  
Vol 52 (10) ◽  
pp. 1277-1279 ◽  
Author(s):  
Fuguang Zuo ◽  
Xi’an Fu ◽  
Hong Liu ◽  
Yongxiang Yu ◽  
Gongqi Yu ◽  
...  

2003 ◽  
Vol 31 (3) ◽  
pp. 597-602 ◽  
Author(s):  
M.A. Knowles ◽  
N. Hornigold ◽  
E. Pitt

In tuberous sclerosis patients, inactivation of the tuberous sclerosis complex tumour-suppressor genes TSC1 and TSC2 contributes to the development of a wide range of hamartomatous lesions. These patients do not, however, show an increased risk of the common adult solid cancers. Recent evidence that the TSC genes play a role in the phosphoinositide 3-kinase pathway, a pathway whose dysregulation is implicated in a wide range of human malignancies, raises the possibility that their inactivation could contribute to the development of some sporadic cancers. To date the only evidence for this comes from the finding of mutations of TSC1 in bladder cancer. The mutation spectrum of TSC1 in bladder cancer and functional evidence from TSC1-gene-replacement studies in bladder tumour cells will be presented. The literature on genetic changes in several other sporadic epithelial cancers reveals relatively common deletions in the region of the TSC genes. In ovarian and gall bladder carcinoma and non-small-cell carcinoma of the lung, deletions in both 16p13 and 9q34 are found at significant frequency. Mutation analyses in such tumours are now merited.


Sign in / Sign up

Export Citation Format

Share Document